Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?
暂无分享,去创建一个
[1] B. Roth,et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.
[2] P. Goldman-Rakic. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[3] G. Aghajanian,et al. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons , 1993, Brain Research.
[4] I. Heuser,et al. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. , 1992, Progress in brain research.
[5] A. Biegon,et al. Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide. , 1990, Archives of general psychiatry.
[6] P. Rakic,et al. Three‐dimensional counting: An accurate and direct method to estimate numbers of cells in sectioned material , 1988, The Journal of comparative neurology.
[7] J. Mazziotta,et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.
[8] P. Magistretti,et al. Metabolic coupling between glia and neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[9] P. Goldman-Rakic,et al. 107 Marked glial neuropathology in prefrontal cortex distinguishes bipolar disorder from schizophrenia , 1997, Schizophrenia Research.
[10] V. Klimek,et al. Distribution ofα2-adrenoceptors in the human locus coeruleus , 1996, Brain Research.
[11] D F Swaab,et al. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.
[12] H. Meltzer,et al. Psychopharmacology : the third generation of progress , 1987 .
[13] S. Sesack,et al. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. , 1998, Cerebral cortex.
[14] T. Robbins,et al. The prefrontal cortex: Executive and cognitive functions. , 1998 .
[15] Patricia S. Goldman-Rakic,et al. Quantitative Three-Dimensional Analysis of the Catecholaminergic Innervation of Identified Neurons in the Macaque Prefrontal Cortex , 1997, The Journal of Neuroscience.
[16] P. Skolnick,et al. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. , 1994, The Journal of pharmacology and experimental therapeutics.
[17] D. Lewis,et al. Parvalbumin‐immunoreactive axon terminals in macaque monkey and human prefrontal cortex: Laminar, regional, and target specificity of type I and type II synapses , 1999, The Journal of comparative neurology.
[18] H. Barbas,et al. Topographic Organization of Connections between the Hypothalamus and Prefrontal Cortex in the Rhesus Monkey , 2022 .
[19] J. Kimura,et al. Cellular localization of brain-derived neurotrophic factor-like immunoreactivity in adult monkey brain , 1999, Brain Research.
[20] S. Foote,et al. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] D. Swaab,et al. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.
[22] R. Duman,et al. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] P S Goldman-Rakic,et al. Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.
[24] P. Goldman-Rakic,et al. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. , 1993, Cerebral cortex.
[25] P. Goldman-Rakic,et al. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.
[26] J. Tepper,et al. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons , 1996, Brain Research.
[27] P. Skolnick,et al. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. , 1993, The Journal of pharmacology and experimental therapeutics.
[28] J. Price,et al. Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] P S Goldman-Rakic,et al. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Skolnick,et al. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. , 1993, European journal of pharmacology.
[31] M E Greenberg,et al. Requirement for BDNF in activity-dependent survival of cortical neurons. , 1994, Science.
[32] H. Gundersen. Stereology of arbitrary particles * , 1986, Journal of microscopy.
[33] E. Nestler,et al. A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.
[34] J. Siuciak,et al. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration , 1996, Brain Research.
[35] D. Lewis. The catecholaminergic innervation of primate prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.
[36] G. Rajkowska,et al. Immunohistochemistry of neural markers for the study of the laminar architecture in celloidin sections from the human cerebral cortex , 1999, Journal of Neuroscience Methods.
[37] J. Mendlewicz,et al. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex , 1997, British Journal of Psychiatry.
[38] H. Meltzer,et al. β-Adrenergic receptor binding in frontal cortex of suicide victims , 1991, Biological Psychiatry.
[39] V. Arango,et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.
[40] G. Rajkowska,et al. Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.
[41] P. Goldman-Rakic,et al. Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. , 1993, Cerebral cortex.
[42] V. Arango,et al. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims , 1999, Biological Psychiatry.
[43] J. Fuster. The Prefrontal Cortex , 1997 .
[44] G. Nowak,et al. Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims , 1995, Brain Research.
[45] P S Goldman-Rakic,et al. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. , 1995, Cerebral cortex.
[46] J. Haycock,et al. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression , 1999, Biological Psychiatry.
[47] P. Skolnick,et al. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. , 1990, European journal of pharmacology.
[48] J. Palacios,et al. Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.
[49] S. Koslow,et al. Catecholamine metabolism and disposition in healthy and depressed subjects. , 1987, Archives of general psychiatry.
[50] Karl J. Friston,et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions , 1993, Psychological Medicine.
[51] R. Duman,et al. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[52] P S Goldman-Rakic,et al. Light and electron microscopic characterization of dopamine‐immunoreactive axons in human cerebral cortex , 1992, The Journal of comparative neurology.
[53] P. Goldman-Rakic,et al. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. , 1995, Cerebral cortex.
[54] P. Goldman-Rakic,et al. Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.
[55] A. Prange. THE PHARMACOLOGY AND BIOCHEMISTRY OF DEPRESSION. , 1964, Diseases of the nervous system.
[56] P. Goldman-Rakic,et al. Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy , 1996, The Journal of comparative neurology.
[57] E. Perry,et al. Postmortem Neurochemical Studies in Depression , 1986, Annals of the New York Academy of Sciences.
[58] E. Robins,et al. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. , 1987, Archives of general psychiatry.
[59] J. Morrison,et al. Noradrenergic innervation of monkey prefrontal cortex: A dopamine‐β‐hydroxylase immunohistochemical study , 1989, The Journal of comparative neurology.
[60] H. Meltzer,et al. Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.
[61] J. García-Sevilla,et al. α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.
[62] André Luxen,et al. Frontal and parietal metabolic disturbances in unipolar depression , 1994, Biological Psychiatry.
[63] S. Pappatà,et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.
[64] G. Ordway,et al. Agonist Binding to α2‐Adrenoceptors Is Elevated in the Locus Coeruleus from Victims of Suicide , 1994 .
[65] G. Rajkowska. Morphometric Methods for Studying the Prefrontal Cortex in Suicide Victims and Psychiatric Patients , 1997, Annals of the New York Academy of Sciences.
[66] G. Aghajanian,et al. 5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex , 1997, The Journal of Neuroscience.
[67] D. Overstreet,et al. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories , 1991, Synapse.
[68] J. Price,et al. Prefrontal cortical projections to the hypothalamus in Macaque monkeys , 1998, The Journal of comparative neurology.
[69] S. Whittemore,et al. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain , 1998, Journal of neuroscience research.
[70] M. Raichle,et al. Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.
[71] P. Goldman-Rakic,et al. The anatomy of dopamine in monkey and human prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.
[72] C. Bowden,et al. Psychomotor performance and monoamine function in bipolar and unipolar affective disorders , 1999, Biological Psychiatry.
[73] J. Haycock,et al. Elevated Tyrosine Hydroxylase in the Locus Coeruleus of Suicide Victims , 1994, Journal of neurochemistry.
[74] Y. Agid,et al. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease , 1999, Neuroscience.
[75] H. Meltzer,et al. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain , 1996, Brain Research.
[76] P. Goldman-Rakic,et al. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.
[77] S. Sesack,et al. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA‐immunoreactive dendrites in rat and monkey cortex , 1995, The Journal of comparative neurology.
[78] M J Campbell,et al. The monoaminergic innervation of primate neocortex. , 1986, Human neurobiology.
[79] J. Schildkraut,et al. The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.
[80] J. John Mann,et al. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.
[81] C. Altar,et al. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[82] C. Montigny,et al. Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.
[83] J. Fuster. Prefrontal Cortex , 2018 .
[84] S. Sesack,et al. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. , 1998, Advances in pharmacology.
[85] S. Sesack,et al. Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex: a study of calretinin-immunoreactive cells , 1995, Neuroscience Letters.